Valerio Therapeutics Société anonyme (EPA:ALVIO)

EPA:ALVIO Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2.64	1.18	6.82	14.59	17.89	14.52
Cash & Short-Term Investments	2.64	1.18	6.82	14.59	17.89	14.52
Cash Growth	-34.10%	-82.72%	-53.26%	-18.45%	23.16%	154.43%
Accounts Receivable	2.75	1.72	1.89	1.47	8.53	6.65
Other Receivables	1.97	1.67	2.99	3.78	2.27	1.6
Receivables	4.72	3.39	4.88	5.25	10.8	8.25
Prepaid Expenses	-0.01	-	1.17	0.29	1.45	0.4
Other Current Assets	0	-	0.13	0.45	-0	-
Total Current Assets	7.35	4.57	13	20.58	30.13	23.18
Property, Plant & Equipment	1.05	1.17	1.53	1.89	2.24	2.56
Goodwill	11.97	11.97	18.06	18.06	18.06	18.06
Other Intangible Assets	-3.26	-3.26	-	-	-	0
Long-Term Deferred Charges	3.26	3.26	2.47	2.47	2.47	2.47
Other Long-Term Assets	0.08	0.22	0.22	0.09	0.16	0.23
Total Assets	20.44	17.93	35.27	43.09	53.06	46.51
Accounts Payable	4.09	5.25	2.46	3.45	2.83	2.76
Accrued Expenses	1.21	1.71	2.62	1.81	0.59	0.81
Short-Term Debt	4.26	3.13	2	0.05	-	-
Current Portion of Long-Term Debt	11.03	7.3	1.45	1	2.95	1.5
Current Portion of Leases	0.22	0.33	0.33	0.34	0.47	0.48
Current Income Taxes Payable	0.46	0.63	0.58	0.48	0.21	0.47
Other Current Liabilities	0	-	1.69	0.02	-	0.02
Total Current Liabilities	21.27	18.34	11.13	7.15	7.06	6.05
Long-Term Debt	7.16	5.63	6.91	8.1	5.08	2.5
Long-Term Leases	0.16	0.18	0.31	0.65	1.43	1.78
Pension & Post-Retirement Benefits	0.04	0.03	0.11	0.17	0.61	0.61
Long-Term Deferred Tax Liabilities	-	-	-	-	0.2	0.42
Other Long-Term Liabilities	0.27	2.01	2.01	4.75	5.74	6.12
Total Liabilities	28.89	26.19	20.47	20.82	20.12	17.47
Common Stock	21.61	21.61	38.59	27.88	23	19.58
Additional Paid-In Capital	15.69	15.69	28.99	27.71	24.58	18.58
Retained Earnings	-47.52	-46.51	-53.14	-33.43	-5.94	1.09
Treasury Stock	-	-0.04	-0.06	-0.08	-0.18	-0.18
Comprehensive Income & Other	1.1	0.31	0.43	0.19	-8.52	-10.03
Total Common Equity	-9.12	-8.93	14.81	22.27	32.94	29.04
Minority Interest	0.67	0.67	-	-	-	-
Shareholders' Equity	-8.45	-8.27	14.81	22.27	32.94	29.04
Total Liabilities & Equity	20.44	17.93	35.27	43.09	53.06	46.51
Total Debt	22.83	16.56	11	10.13	9.93	6.26
Net Cash (Debt)	-20.19	-15.38	-4.18	4.45	7.95	8.27
Net Cash Growth	-	-	-	-44.02%	-3.79%	-
Net Cash Per Share	-0.13	-0.10	-0.03	0.04	0.09	0.11
Filing Date Shares Outstanding	488.85	153.88	154	110.93	111.08	78.05
Total Common Shares Outstanding	154.36	153.88	154	110.93	91.57	78.05
Working Capital	-13.91	-13.77	1.87	13.43	23.07	17.13
Book Value Per Share	-0.06	-0.06	0.10	0.20	0.36	0.37
Tangible Book Value	-17.83	-17.64	-3.25	4.21	14.88	10.97
Tangible Book Value Per Share	-0.12	-0.11	-0.02	0.04	0.16	0.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.